Last reviewed · How we verify
Epacadostat 100 mg — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Epacadostat 100 mg (Epacadostat 100 mg) — Merck Sharp & Dohme LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Epacadostat 100 mg TARGET | Epacadostat 100 mg | Merck Sharp & Dohme LLC | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Epacadostat 100 mg CI watch — RSS
- Epacadostat 100 mg CI watch — Atom
- Epacadostat 100 mg CI watch — JSON
- Epacadostat 100 mg alone — RSS
Cite this brief
Drug Landscape (2026). Epacadostat 100 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/epacadostat-100-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab